Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cirtran (CIRX) EBT (2017 - 2025)

Historic EBT for Cirtran (CIRX) over the last 14 years, with Q3 2025 value amounting to -$444890.0.

  • Cirtran's EBT rose 5056.52% to -$444890.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year decrease of 11052.26%. This contributed to the annual value of -$2.7 million for FY2024, which is 11331.98% down from last year.
  • As of Q3 2025, Cirtran's EBT stood at -$444890.0, which was up 5056.52% from -$562750.0 recorded in Q2 2025.
  • In the past 5 years, Cirtran's EBT registered a high of $21.2 million during Q4 2023, and its lowest value of -$899953.0 during Q3 2024.
  • Moreover, its 5-year median value for EBT was -$304839.0 (2021), whereas its average is $748620.1.
  • Its EBT has fluctuated over the past 5 years, first soared by 509908.4% in 2023, then crashed by 33739.06% in 2024.
  • Cirtran's EBT (Quarter) stood at -$304839.0 in 2021, then tumbled by 39.17% to -$424256.0 in 2022, then skyrocketed by 5099.08% to $21.2 million in 2023, then plummeted by 104.18% to -$887090.0 in 2024, then surged by 49.85% to -$444890.0 in 2025.
  • Its EBT was -$444890.0 in Q3 2025, compared to -$562750.0 in Q2 2025 and -$146113.0 in Q1 2025.